Life Technologies to Buy BioTrove, Which Will Form Mass Spec Sample Prep Company

The deal will expand Life Technologies’ PCR portfolio, while BioTrove will spin out a subsidiary called Biocius Life Sciences for its mass spec sample handling business.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.